Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Change in Accured Expenses (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Change in Accured Expenses for 3 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 220.25% to -$2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.4 million through Dec 2025, down 100.84% year-over-year, with the annual reading at -$2.4 million for FY2025, 100.84% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$2.3 million at Mereo BioPharma, down from -$673000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $4.2 million in Q2 2023, with the low at -$3.1 million in Q1 2023.
  • Average Change in Accured Expenses over 3 years is -$358000.0, with a median of -$749000.0 recorded in 2024.
  • Peak annual rise in Change in Accured Expenses hit 58.79% in 2024, while the deepest fall reached 442.47% in 2024.
  • Over 3 years, Change in Accured Expenses stood at -$1.7 million in 2023, then surged by 58.79% to -$706000.0 in 2024, then crashed by 220.25% to -$2.3 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$2.3 million, -$673000.0, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.